0001144204-17-048372.txt : 20170918 0001144204-17-048372.hdr.sgml : 20170918 20170918061436 ACCESSION NUMBER: 0001144204-17-048372 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170915 FILED AS OF DATE: 20170918 DATE AS OF CHANGE: 20170918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHAH JAISIM CENTRAL INDEX KEY: 0001242133 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36150 FILM NUMBER: 171088946 MAIL ADDRESS: STREET 1: C/O PROTINE DESIGN LAB STREET 2: 37481 MARSTEN DR CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sorrento Therapeutics, Inc. CENTRAL INDEX KEY: 0000850261 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 330344842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4955 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-203-4100 MAIL ADDRESS: STREET 1: 4955 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: QUIKBYTE SOFTWARE INC DATE OF NAME CHANGE: 19920703 4/A 1 v475336_4a.xml OWNERSHIP DOCUMENT X0306 4/A 2017-09-15 2017-09-15 0 0000850261 Sorrento Therapeutics, Inc. SRNE 0001242133 SHAH JAISIM C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTORS PLACE SAN DIEGO CA 92121 1 0 0 0 Stock Options 1.80 2017-09-15 4 A 0 35000 0.00 A 2027-09-15 Common Stock 35000 35000 D This amended report on Form 4 is being filed to amend the Form 4 filed by the reporting person on September 15, 2017 to correct the exercise price, which was inadvertently reported as $1.75. 1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the reporting person's continued service on the issuer's board of directors on each such date. /s/ Henry Ji, Ph.D., as Attorney-in-Fact 2017-09-18